Trince
PrivateLast Round
VC Round
Dec 1, 2025
Total Funding Raised
$9.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Trince operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a VC Round in December 2025.
Trince is a biotechnology company that develops a proprietary photoporation platform for efficient and gentle intracellular delivery of molecules into various cell types.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trince Comparables
Compare Trince with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellFE | 86% | |
| Avectas | 86% | |
| Kytopen | 84% |
For institutional investors. Book with your work email.
Trince Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2025 | ||||
| Convertible Debt | Jan 1, 2025 | ||||
| Grant | Mar 19, 2024 | ||||
| Series A | Dec 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trince Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Qbic II | Series A |
| Novalis Biotech | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 5, representing 23% of headcount.
- Jul 26, 2026
Monthly visitors grew 52% MoM, from 1.3K to 2K.
For institutional investors. Book with your work email.
Trince Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trince's valuation, stock price, and market status.
Is Trince a public or private company?
Trince is a private company.
What is the current stock price of Trince?
Trince is a private company, so its shares have no public market price. Caplight tracks Trince's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trince worth (valuation)?
Valuation information for Trince is not publicly available.
Can I buy Trince stock?
Trince shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trince's last funding round?
Trince's most recent funding round was VC Round on December 1, 2025.
Who are the main investors in Trince?
Key investors in Trince include Novalis Biotech.
Will Trince IPO soon?
No public IPO plans have been announced for Trince.
How can I track Trince secondary market activity?
Caplight tracks bids, offers, and trades in Trince's shares on secondary markets.